Dolby Laboratories, INC 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

NYSE
Dolby Laboratories reported a decrease in revenue for the fiscal quarter ended June 26, 2026, with licensing revenue down 3% and products and services revenue down 12%, though gross profit and net income remained robust.
NYSE
Dolby Laboratories reported Q2 2026 revenue of $395.6 million, driven by licensing growth and continued adoption of Dolby Atmos and Dolby Vision.
NYSE
Dolby Laboratories reports a 3% decline in Q1 fiscal 2026 revenue and a 21% drop in net income, while advancing strategic initiatives in mobile, automotive, and new platforms.
NYSE
Dolby Laboratories announced a significant increase in revenue and net income for the third fiscal quarter of 2025, primarily driven by robust licensing performance across its branded technologies and patent portfolios.
NYSE
Dolby Laboratories' Q2 2025 results show a slight increase in total revenue, driven by licensing, with strategic restructuring actions underway.
NYSE
Dolby Laboratories' Q1 2025 results show increased revenue driven by licensing, particularly in mobile and automotive sectors, alongside strategic restructuring efforts.
NYSE
Dolby Laboratories' third-quarter results show a slight decrease in revenue and increased operating income, alongside ongoing restructuring activities.
NYSE
Dolby Laboratories' second quarter fiscal 2024 results show a slight decrease in revenue compared to the same period last year, with licensing revenue experiencing a minor dip.
NYSE
Dolby Laboratories' first quarter of fiscal year 2024 saw a decrease in revenue compared to the same period last year, primarily due to challenging macroeconomic conditions impacting licensing and product sales.